Kanbi  Pharma  Teknoloji  Limite
101020-79-5 Ademetionine 1,4-Butanedisulfonat

101020-79-5 Ademetionine 1,4-Butanedisulfonat

CAS101020-79-5
MF:C42H74N12O28S8
MW:1451.59
EINECS:600-154-4
MDL nimewo: MFCD11111819

Voye rechèch
Dekri teren

Spesifikasyon:

Aparans  
   

 

Aplikasyon:

Klinikman itilize pou amelyore fonksyon fwa. Konbine ak L-dopa pou tretman maladi Parkinson la, li ka amelyore efikasite L-dopa epi redwi efè segondè yo.
 

Sinonim:

MENM-1,4-Butanedisulfonat

101020-79-5

MENM-14-Butanedisulfonat

Ademethionine 1,4-Butanedisulfonate

[(3S)-3-amino-3-karboxipropil]-[[(2S,3S,4R,5R)-5-({6-aminopurin-9-il){{ 11}},4-dihydro xyoxolan-2-il]methyl]-methylsulfanyum;butan-1,4-disulfonat;butan-1,4-disulfonik asid

S-Adenosylmethione-1,4-butanedisulfonat

S-Adenosyl-L-Methionine 1,4-butanedisulfonat sèl sodyòm


Foto pwodwi:

 

 

 

 

Pou plis enfòmasyon sou pwodwi, tanpri kontakte nou !!!

 

 

Baj popilè: 101020-79-5 ademetionine 1,4-butanedisulfonat, Lachin 101020-79-5 ademetionine 1,4-butanedisulfonat manifaktirè, founisè

Inquiry
goTop

(0/10)

clearall